High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

Author： Ianni Mauro Di   Ballanti Stelvio   Iodice Giuseppe   Reale Antonia   Falzetti Franca   Minelli Olivia   Serio Gabriella   Martelli Massimo F   Dammacco Franco   Vacca Angelo   Ria Roberto  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.17, Iss.1, 2012-01, pp. : 23-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

By Hänel M.   Kröger N.   Sonnenberg S.   Bornhäuser M.   Krüger W.   Kroschinsky F.   Hänel A.   Metzner B.   Birkmann J.   Schmid B.   Hoffknecht M.   Fiedler F.   Ehninger G.   Zander A.  

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 96-102

Springer Publishing Company

Access to resources Recommend Favorite

Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease

By Kömürcü Ş.   Özet A.   Altundag M.   Arpaci F.   Öztürk B.   Celasun B.   Tezcan Y.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 57-58

Springer Publishing Company

Access to resources Recommend Favorite

Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients

By Holowiecki J.   Giebel S.   Wojnar J.   Krawczyk-Kulis M.   Stella-Holowiecka B.   Kachel L.   Wojciechowska M.   Markiewicz M.   Kata D.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3378-3383

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

By Kim Min   Kim Shin   Lee Sung   Sym Sun   Lee Dae   Jang Seongsoo   Park Chan   Chi Hyun   Huh Jooryung   Suh Cheolwon  

Annals of Hematology, Vol. 86, Iss. 6, 2007-06 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

By Ritchie D.   Seymour J.   Grigg A.   Roberts A.   Hoyt R.   Thompson S.   Szer J.   Prince H.  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 101-105

Springer Publishing Company

Access to resources Recommend Favorite